{"gene":"PF3D7_1362400","run_date":"2026-09-08T14:19:06","timeline":{"discoveries":[{"year":2009,"finding":"Pcalp (PF3D7_1362400) localizes to the nucleolus of P. falciparum parasites. The protein is myristoylated at Gly2 and palmitoylated at Cys3 and Cys22 in its N-terminal domain. Palmitoylation status dictates nucleolar vs. nuclear localization. An embedded nuclear localization sequence confers nucleolar targeting. These targeting signals function in mammalian cells as well as in the parasite.","method":"C-terminally tagged calpain expressed from endogenous locus in P. falciparum; mutagenesis of myristoylation/palmitoylation sites; chimeric reporter constructs tested in parasite and mammalian cells; immunofluorescence/confocal microscopy","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — endogenous tagging, mutagenesis of active targeting residues, chimeric constructs with multiple orthogonal methods in a single rigorous study","pmids":["19239622"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Pcalp (PF3D7_1362400) is essential for P. falciparum intraerythrocytic development. Gene disruption (double cross-over and single cross-over) and allelic replacement with a catalytic-cysteine missense mutation all failed, while synonymous allelic replacement succeeded, indicating that both the gene and its proteolytic activity are required. Conditional knockdown via FKBP-Shield1 system showed that depletion of Pcalp greatly impairs parasite growth and causes a delay in transition out of ring stage and failure to progress to S phase, placing Pcalp in cell cycle progression.","method":"Attempted gene disruption (double and single cross-over); attempted missense allelic replacement at catalytic Cys; FKBP degradation-domain conditional knockdown (Shield1-regulatable calpain-GFP-FKBP fusion at endogenous locus); growth assays; cell cycle staging","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic approaches (failed disruptions as genetic evidence for essentiality, plus conditional knockdown with defined cell-cycle phenotype) in a single rigorous study","pmids":["19164769"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"The active form of Pcalp (PF3D7_1362400) consists solely of catalytic subdomain IIa, which contains the catalytic triad (Cys-His-Asn) and functions as a monomer. Recombinant subdomain IIa displayed protease activity measured by fluorogenic substrate assay and gelatin zymography; mutation of catalytic triad residues abolished activity.","method":"Heterologous expression and purification of recombinant subdomain IIa; fluorogenic substrate assay; gelatin zymography; catalytic triad mutagenesis; molecular homology modeling","journal":"Malaria journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro enzymatic assay with mutagenesis but single lab, single study","pmids":["23374507"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"finding":"Pcalp (PF3D7_1362400) displays intracellular calcium-dependent cysteine protease activity detectable in live intraerythrocytic trophozoite-stage P. falciparum. Activity was measured using the fluorogenic substrate Z-Phe-Arg-MCA and was inhibited by the cysteine protease inhibitor E-64 and by the calpain-selective inhibitor ALLN. Manipulation of cytosolic Ca2+ via calmodulin inhibitor (calmidazolium) or SERCA inhibitor (thapsigargin) modulated Pcalp activity, establishing calcium dependence in the parasite cell.","method":"Confocal microscopy and spectrofluorimetry of live infected RBCs using fluorogenic substrate Z-Phe-Arg-MCA; pharmacological modulation of Ca2+ with calmidazolium and thapsigargin; inhibitor assays with E-64 and ALLN","journal":"Analytical biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live-cell enzymatic activity assay with multiple pharmacological tools validating calcium dependence and cysteine protease identity, single lab","pmids":["25281458"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"finding":"Pcalp (PF3D7_1362400) is the principal calcium-stimulated cysteine protease target of organotellurane compounds in P. falciparum intraerythrocytic stages; inhibition of Pcalp activity correlated with reduced parasitemia in vitro in 3D7 and W2 strains.","method":"Intracellular protease inhibition assay using ER Ca2+-ATPase inhibitor to distinguish calcium-dependent (calpain) from other cysteine proteases; in vitro parasite growth inhibition assay","journal":"Parasitology international","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological/biochemical assay identifying Pcalp as target, but indirect (no direct binding/enzyme assay with purified Pcalp), single lab","pmids":["26384965"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"},{"species":"Plasmodium falciparum","strain":"W2"}]},{"year":2015,"finding":"Pcalp (PF3D7_1362400) potentially interacts with P. falciparum Hsp60 (Pf-Hsp60). Co-immunoprecipitation from infected RBCs pulled down both proteins together; immunofluorescence showed co-localization. Treatment with the Hsp60 inhibitor mizoribine attenuated Pcalp enzymatic activity and P. falciparum growth.","method":"Immunoprecipitation from Pf-infected RBCs; immunofluorescence co-localization; Hsp60 inhibitor (mizoribine) effect on calpain enzymatic activity and parasite growth","journal":"The Korean journal of parasitology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP without reciprocal pull-down, pharmacological inhibitor not specific to the interaction, single lab","pmids":["26797432"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Confocal microscopy with anti-Pf-calpain polyclonal antibodies directed against peptides specific to Pcalp (PF3D7_1362400) showed cytoplasmic localization in intraerythrocytic parasites across all erythrocytic stages, with expression increasing as late ring stage matures into early trophozoite.","method":"Polyclonal antibodies against Pcalp-specific synthetic peptides; confocal immunofluorescence microscopy across erythrocytic stages","journal":"Experimental parasitology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single antibody-based localization study, single lab, no functional consequence linked","pmids":["19861123"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"finding":"Genome analysis identified a single calpain homolog gene (Pcalp/PF3D7_1362400) in P. falciparum; only the catalytic domain showed significant similarity to vertebrate calpains, and putative PEST-sequence-containing substrates were identified in the proteome. No calpastatin homolog was found in the genome.","method":"Bioinformatic genome analysis; PEST score prediction for annotated proteins; BLAST homology searches","journal":"Malaria journal","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation","pmids":["12857354"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"Pcalp (PF3D7_1362400) is an essential, nucleolus-localized cysteine protease in P. falciparum that is post-translationally regulated by N-terminal myristoylation (Gly2) and palmitoylation (Cys3, Cys22) — with palmitoylation status controlling its nucleolar versus nuclear localization — functions as an active monomer via a catalytic subdomain IIa containing a Cys-His-Asn triad, displays calcium-dependent protease activity in intraerythrocytic trophozoites, is required for cell cycle progression (ring-to-trophozoite transition and S-phase entry), and potentially interacts with Pf-Hsp60; loss of its proteolytic activity (catalytic-Cys mutation) or depletion by conditional knockdown severely impairs parasite growth, establishing it as an essential enzyme."},"narrative":{"mechanistic_narrative":"Pcalp (PF3D7_1362400) is an essential calcium-dependent cysteine protease that governs intraerythrocytic cell cycle progression in Plasmodium falciparum [PMID:19164769]. Genetic evidence establishes both the gene and its proteolytic activity as required: gene disruption and catalytic-cysteine allelic replacement both fail, and conditional knockdown delays the ring-to-trophozoite transition and blocks S-phase entry [PMID:19164769]. The enzyme is active as a monomer through its catalytic subdomain IIa, which carries a Cys-His-Asn catalytic triad whose mutation abolishes protease activity in vitro [PMID:23374507], and in live trophozoites its activity is calcium-dependent and sensitive to the cysteine-protease inhibitor E-64 and the calpain-selective inhibitor ALLN [PMID:25281458]. Pcalp is targeted to the nucleolus through an N-terminal lipidation program — myristoylation at Gly2 and palmitoylation at Cys3 and Cys22 — with palmitoylation status dictating nucleolar versus nuclear localization [PMID:19239622]. Beyond a possible interaction with Pf-Hsp60 [PMID:26797432], the physiological substrates through which Pcalp drives cell cycle progression have not been characterized in the available corpus.","teleology":[{"year":2003,"claim":"Before any functional work, it was unknown whether P. falciparum encoded a calpain at all; genome analysis established a single calpain homolog and framed its predicted enzymatic identity and candidate substrates.","evidence":"bioinformatic genome analysis, PEST-score prediction, and BLAST homology searches","pmids":["12857354"],"confidence":"Low","gaps":["purely computational, no experimental validation of catalytic activity or substrates","absence of a calpastatin homolog leaves the regulatory mechanism unaddressed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Having a candidate gene, the question became where the protein acts and how it gets there; endogenous tagging and lipidation-site mutagenesis showed nucleolar targeting controlled by N-terminal myristoylation and palmitoylation.","evidence":"C-terminally endogenously tagged Pcalp, myristoylation/palmitoylation site mutagenesis, and chimeric reporters imaged in parasite and mammalian cells","pmids":["19239622"],"confidence":"High","gaps":["the enzymes catalyzing myristoylation and palmitoylation are not identified","no functional consequence of nucleolar versus nuclear localization for catalytic activity established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"A complementary antibody-based study addressed stage-specific expression, reporting cytoplasmic signal across erythrocytic stages that rises from late ring into early trophozoite.","evidence":"polyclonal antibodies against Pcalp-specific peptides and confocal immunofluorescence across erythrocytic stages","pmids":["19861123"],"confidence":"Low","gaps":["cytoplasmic localization contrasts with the endogenously tagged nucleolar signal, and the discrepancy is unresolved","no functional consequence linked to the expression pattern"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"The central question of biological importance was answered by genetics: multiple failed knockouts, a failed catalytic-Cys replacement, and conditional knockdown showed Pcalp and its proteolytic activity are essential and required for cell cycle progression.","evidence":"attempted single/double cross-over disruption, catalytic-Cys missense allelic replacement, FKBP-Shield1 conditional knockdown with growth and cell-cycle staging","pmids":["19164769"],"confidence":"High","gaps":["the molecular substrates whose cleavage drives the ring-to-trophozoite and S-phase transitions are unidentified","how essentiality relates to nucleolar localization is not established"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"The architecture of the active enzyme was unresolved; recombinant work showed the active form is catalytic subdomain IIa alone, functioning as a monomer via a Cys-His-Asn triad.","evidence":"heterologous expression of recombinant subdomain IIa, fluorogenic substrate assay, gelatin zymography, catalytic-triad mutagenesis, and homology modeling","pmids":["23374507"],"confidence":"Medium","gaps":["single-lab in vitro finding without full-length enzyme comparison","no structural determination beyond homology modeling","substrate specificity of the isolated subdomain not defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"claim":"Whether the protease behaves as a calcium-dependent calpain inside the living parasite was tested directly, confirming calcium-dependent cysteine-protease activity in intraerythrocytic trophozoites.","evidence":"live-cell fluorogenic substrate (Z-Phe-Arg-MCA) assays with E-64 and ALLN inhibition and Ca2+ modulation by calmidazolium and thapsigargin","pmids":["25281458"],"confidence":"Medium","gaps":["the fluorogenic substrate is not Pcalp-specific, so activity attribution is inferential","the source and dynamics of the activating Ca2+ signal are not resolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"claim":"Two studies probed pharmacological and physical context: organotelluranes were identified as inhibitors of the calcium-stimulated protease, and a candidate Hsp60 partnership was reported.","evidence":"intracellular protease inhibition assays with Ca2+-ATPase discrimination and growth assays (3D7, W2); co-immunoprecipitation, immunofluorescence co-localization, and mizoribine treatment for the Hsp60 link","pmids":["26384965","26797432"],"confidence":"Low","gaps":["organotellurane targeting is inferred without direct binding to purified Pcalp","Hsp60 interaction rests on a single non-reciprocal Co-IP and a non-specific inhibitor","functional consequence of the putative Hsp60 association is undefined"],"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"},{"species":"Plasmodium falciparum","strain":"W2"}]},{"year":null,"claim":"The identity of the physiological substrates cleaved by Pcalp to drive the ring-to-trophozoite transition and S-phase entry, and how its nucleolar localization couples to this cell-cycle role, remain unknown.","evidence":"no timeline discovery defines an endogenous Pcalp substrate or a mechanistic link between localization and cell-cycle function","pmids":[],"confidence":"Low","gaps":["no validated endogenous substrate identified","regulation in the absence of a calpastatin homolog is unexplained","reconciliation of nucleolar versus cytoplasmic localization reports is unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["PF-HSP60 (PUTATIVE, SINGLE NON-RECIPROCAL CO-IP)"],"other_free_text":["N-terminally myristoylated at Gly2 and palmitoylated at Cys3 and Cys22; palmitoylation status controls nucleolar versus nuclear localization [#0]","Active form is catalytic subdomain IIa functioning as a monomer with a Cys-His-Asn catalytic triad [#2]","Activity is calcium-dependent in live trophozoites and inhibited by E-64 and ALLN [#3]","Essential gene: proteolytic activity required, depletion delays ring-to-trophozoite transition and blocks S-phase entry [#1]","No calpastatin homolog identified in the P. falciparum genome [#7]","Reported inhibited by organotellurane compounds [#5 correction: #4]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"15582526","id":"PMC_15582526","title":"Cysteine proteases of malaria parasites.","date":"2004","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15582526","citation_count":262,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19342550","id":"PMC_19342550","title":"Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19342550","citation_count":120,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21660657","id":"PMC_21660657","title":"Falcipains and other cysteine proteases of malaria parasites.","date":"2011","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/21660657","citation_count":116,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19164769","id":"PMC_19164769","title":"A calpain unique to alveolates is essential in Plasmodium falciparum and its knockdown reveals an involvement in pre-S-phase development.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19164769","citation_count":85,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19752273","id":"PMC_19752273","title":"Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.","date":"2009","source":"Antimicrobial agents and chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/19752273","citation_count":67,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21903871","id":"PMC_21903871","title":"The malaria parasite progressively dismantles the host erythrocyte cytoskeleton for efficient egress.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/21903871","citation_count":63,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12850260","id":"PMC_12850260","title":"Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum.","date":"2003","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12850260","citation_count":45,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"2018795","id":"PMC_2018795","title":"Effect of calpain inhibitors on the invasion of human erythrocytes by the parasite Plasmodium falciparum.","date":"1991","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2018795","citation_count":44,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19239622","id":"PMC_19239622","title":"Fatty acid acylation regulates trafficking of the unusual Plasmodium falciparum calpain to the nucleolus.","date":"2009","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19239622","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23332153","id":"PMC_23332153","title":"A host GPCR signaling network required for the cytolysis of infected cells facilitates release of apicomplexan parasites.","date":"2013","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/23332153","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20056606","id":"PMC_20056606","title":"Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20056606","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16452306","id":"PMC_16452306","title":"Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.","date":"2006","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16452306","citation_count":14,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23374507","id":"PMC_23374507","title":"Identification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug development.","date":"2013","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/23374507","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12106878","id":"PMC_12106878","title":"Erythrocyte calpain is dispensable for malaria parasite invasion and growth.","date":"2002","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/12106878","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26384965","id":"PMC_26384965","title":"Hypervalent organotellurium compounds as inhibitors of P. falciparum calcium-dependent cysteine proteases.","date":"2015","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/26384965","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25281458","id":"PMC_25281458","title":"Specific calpain activity evaluation in Plasmodium parasites.","date":"2014","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25281458","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12857354","id":"PMC_12857354","title":"PEST sequences in the malaria parasite Plasmodium falciparum: a genomic study.","date":"2003","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/12857354","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26797432","id":"PMC_26797432","title":"Potential Interaction of Plasmodium falciparum Hsp60 and Calpain.","date":"2015","source":"The Korean journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/26797432","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22477194","id":"PMC_22477194","title":"Synthesis and evaluation of peptidyl α,β-unsaturated carbonyl derivatives as anti-malarial calpain inhibitors.","date":"2012","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/22477194","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19557368","id":"PMC_19557368","title":"Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.","date":"2009","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/19557368","citation_count":7,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19861123","id":"PMC_19861123","title":"Confocal microscopic findings of cysteine protease calpain in Plasmodium falciparum.","date":"2009","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/19861123","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"39217276","id":"PMC_39217276","title":"Biogenically synthesized green silver nanoparticles exhibit antimalarial activity.","date":"2024","source":"Discover nano","url":"https://pubmed.ncbi.nlm.nih.gov/39217276","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"42467294","id":"PMC_42467294","title":"Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria.","date":"2026","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/42467294","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["calpain"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13389,"output_tokens":2643,"usd":0.039906,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8099,"output_tokens":3461,"usd":0.06351,"stage2_stop_reason":"end_turn"},"total_usd":0.103416,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"Pcalp (PF3D7_1362400) localizes to the nucleolus of P. falciparum parasites. The protein is myristoylated at Gly2 and palmitoylated at Cys3 and Cys22 in its N-terminal domain. Palmitoylation status dictates nucleolar vs. nuclear localization. An embedded nuclear localization sequence confers nucleolar targeting. These targeting signals function in mammalian cells as well as in the parasite.\",\n      \"method\": \"C-terminally tagged calpain expressed from endogenous locus in P. falciparum; mutagenesis of myristoylation/palmitoylation sites; chimeric reporter constructs tested in parasite and mammalian cells; immunofluorescence/confocal microscopy\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — endogenous tagging, mutagenesis of active targeting residues, chimeric constructs with multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"19239622\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pcalp (PF3D7_1362400) is essential for P. falciparum intraerythrocytic development. Gene disruption (double cross-over and single cross-over) and allelic replacement with a catalytic-cysteine missense mutation all failed, while synonymous allelic replacement succeeded, indicating that both the gene and its proteolytic activity are required. Conditional knockdown via FKBP-Shield1 system showed that depletion of Pcalp greatly impairs parasite growth and causes a delay in transition out of ring stage and failure to progress to S phase, placing Pcalp in cell cycle progression.\",\n      \"method\": \"Attempted gene disruption (double and single cross-over); attempted missense allelic replacement at catalytic Cys; FKBP degradation-domain conditional knockdown (Shield1-regulatable calpain-GFP-FKBP fusion at endogenous locus); growth assays; cell cycle staging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic approaches (failed disruptions as genetic evidence for essentiality, plus conditional knockdown with defined cell-cycle phenotype) in a single rigorous study\",\n      \"pmids\": [\"19164769\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The active form of Pcalp (PF3D7_1362400) consists solely of catalytic subdomain IIa, which contains the catalytic triad (Cys-His-Asn) and functions as a monomer. Recombinant subdomain IIa displayed protease activity measured by fluorogenic substrate assay and gelatin zymography; mutation of catalytic triad residues abolished activity.\",\n      \"method\": \"Heterologous expression and purification of recombinant subdomain IIa; fluorogenic substrate assay; gelatin zymography; catalytic triad mutagenesis; molecular homology modeling\",\n      \"journal\": \"Malaria journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro enzymatic assay with mutagenesis but single lab, single study\",\n      \"pmids\": [\"23374507\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Pcalp (PF3D7_1362400) displays intracellular calcium-dependent cysteine protease activity detectable in live intraerythrocytic trophozoite-stage P. falciparum. Activity was measured using the fluorogenic substrate Z-Phe-Arg-MCA and was inhibited by the cysteine protease inhibitor E-64 and by the calpain-selective inhibitor ALLN. Manipulation of cytosolic Ca2+ via calmodulin inhibitor (calmidazolium) or SERCA inhibitor (thapsigargin) modulated Pcalp activity, establishing calcium dependence in the parasite cell.\",\n      \"method\": \"Confocal microscopy and spectrofluorimetry of live infected RBCs using fluorogenic substrate Z-Phe-Arg-MCA; pharmacological modulation of Ca2+ with calmidazolium and thapsigargin; inhibitor assays with E-64 and ALLN\",\n      \"journal\": \"Analytical biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live-cell enzymatic activity assay with multiple pharmacological tools validating calcium dependence and cysteine protease identity, single lab\",\n      \"pmids\": [\"25281458\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pcalp (PF3D7_1362400) is the principal calcium-stimulated cysteine protease target of organotellurane compounds in P. falciparum intraerythrocytic stages; inhibition of Pcalp activity correlated with reduced parasitemia in vitro in 3D7 and W2 strains.\",\n      \"method\": \"Intracellular protease inhibition assay using ER Ca2+-ATPase inhibitor to distinguish calcium-dependent (calpain) from other cysteine proteases; in vitro parasite growth inhibition assay\",\n      \"journal\": \"Parasitology international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological/biochemical assay identifying Pcalp as target, but indirect (no direct binding/enzyme assay with purified Pcalp), single lab\",\n      \"pmids\": [\"26384965\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"W2\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Pcalp (PF3D7_1362400) potentially interacts with P. falciparum Hsp60 (Pf-Hsp60). Co-immunoprecipitation from infected RBCs pulled down both proteins together; immunofluorescence showed co-localization. Treatment with the Hsp60 inhibitor mizoribine attenuated Pcalp enzymatic activity and P. falciparum growth.\",\n      \"method\": \"Immunoprecipitation from Pf-infected RBCs; immunofluorescence co-localization; Hsp60 inhibitor (mizoribine) effect on calpain enzymatic activity and parasite growth\",\n      \"journal\": \"The Korean journal of parasitology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP without reciprocal pull-down, pharmacological inhibitor not specific to the interaction, single lab\",\n      \"pmids\": [\"26797432\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Confocal microscopy with anti-Pf-calpain polyclonal antibodies directed against peptides specific to Pcalp (PF3D7_1362400) showed cytoplasmic localization in intraerythrocytic parasites across all erythrocytic stages, with expression increasing as late ring stage matures into early trophozoite.\",\n      \"method\": \"Polyclonal antibodies against Pcalp-specific synthetic peptides; confocal immunofluorescence microscopy across erythrocytic stages\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single antibody-based localization study, single lab, no functional consequence linked\",\n      \"pmids\": [\"19861123\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Genome analysis identified a single calpain homolog gene (Pcalp/PF3D7_1362400) in P. falciparum; only the catalytic domain showed significant similarity to vertebrate calpains, and putative PEST-sequence-containing substrates were identified in the proteome. No calpastatin homolog was found in the genome.\",\n      \"method\": \"Bioinformatic genome analysis; PEST score prediction for annotated proteins; BLAST homology searches\",\n      \"journal\": \"Malaria journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation\",\n      \"pmids\": [\"12857354\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"Pcalp (PF3D7_1362400) is an essential, nucleolus-localized cysteine protease in P. falciparum that is post-translationally regulated by N-terminal myristoylation (Gly2) and palmitoylation (Cys3, Cys22) — with palmitoylation status controlling its nucleolar versus nuclear localization — functions as an active monomer via a catalytic subdomain IIa containing a Cys-His-Asn triad, displays calcium-dependent protease activity in intraerythrocytic trophozoites, is required for cell cycle progression (ring-to-trophozoite transition and S-phase entry), and potentially interacts with Pf-Hsp60; loss of its proteolytic activity (catalytic-Cys mutation) or depletion by conditional knockdown severely impairs parasite growth, establishing it as an essential enzyme.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Pcalp (PF3D7_1362400) is an essential calcium-dependent cysteine protease that governs intraerythrocytic cell cycle progression in Plasmodium falciparum [#1]. Genetic evidence establishes both the gene and its proteolytic activity as required: gene disruption and catalytic-cysteine allelic replacement both fail, and conditional knockdown delays the ring-to-trophozoite transition and blocks S-phase entry [#1]. The enzyme is active as a monomer through its catalytic subdomain IIa, which carries a Cys-His-Asn catalytic triad whose mutation abolishes protease activity in vitro [#2], and in live trophozoites its activity is calcium-dependent and sensitive to the cysteine-protease inhibitor E-64 and the calpain-selective inhibitor ALLN [#3]. Pcalp is targeted to the nucleolus through an N-terminal lipidation program \\u2014 myristoylation at Gly2 and palmitoylation at Cys3 and Cys22 \\u2014 with palmitoylation status dictating nucleolar versus nuclear localization [#0]. Beyond a possible interaction with Pf-Hsp60 [#5], the physiological substrates through which Pcalp drives cell cycle progression have not been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Before any functional work, it was unknown whether P. falciparum encoded a calpain at all; genome analysis established a single calpain homolog and framed its predicted enzymatic identity and candidate substrates.\",\n      \"evidence\": \"bioinformatic genome analysis, PEST-score prediction, and BLAST homology searches\",\n      \"pmids\": [\"12857354\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"purely computational, no experimental validation of catalytic activity or substrates\",\n        \"absence of a calpastatin homolog leaves the regulatory mechanism unaddressed\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Having a candidate gene, the question became where the protein acts and how it gets there; endogenous tagging and lipidation-site mutagenesis showed nucleolar targeting controlled by N-terminal myristoylation and palmitoylation.\",\n      \"evidence\": \"C-terminally endogenously tagged Pcalp, myristoylation/palmitoylation site mutagenesis, and chimeric reporters imaged in parasite and mammalian cells\",\n      \"pmids\": [\"19239622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"the enzymes catalyzing myristoylation and palmitoylation are not identified\",\n        \"no functional consequence of nucleolar versus nuclear localization for catalytic activity established\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A complementary antibody-based study addressed stage-specific expression, reporting cytoplasmic signal across erythrocytic stages that rises from late ring into early trophozoite.\",\n      \"evidence\": \"polyclonal antibodies against Pcalp-specific peptides and confocal immunofluorescence across erythrocytic stages\",\n      \"pmids\": [\"19861123\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"cytoplasmic localization contrasts with the endogenously tagged nucleolar signal, and the discrepancy is unresolved\",\n        \"no functional consequence linked to the expression pattern\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The central question of biological importance was answered by genetics: multiple failed knockouts, a failed catalytic-Cys replacement, and conditional knockdown showed Pcalp and its proteolytic activity are essential and required for cell cycle progression.\",\n      \"evidence\": \"attempted single/double cross-over disruption, catalytic-Cys missense allelic replacement, FKBP-Shield1 conditional knockdown with growth and cell-cycle staging\",\n      \"pmids\": [\"19164769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"the molecular substrates whose cleavage drives the ring-to-trophozoite and S-phase transitions are unidentified\",\n        \"how essentiality relates to nucleolar localization is not established\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The architecture of the active enzyme was unresolved; recombinant work showed the active form is catalytic subdomain IIa alone, functioning as a monomer via a Cys-His-Asn triad.\",\n      \"evidence\": \"heterologous expression of recombinant subdomain IIa, fluorogenic substrate assay, gelatin zymography, catalytic-triad mutagenesis, and homology modeling\",\n      \"pmids\": [\"23374507\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"single-lab in vitro finding without full-length enzyme comparison\",\n        \"no structural determination beyond homology modeling\",\n        \"substrate specificity of the isolated subdomain not defined\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Whether the protease behaves as a calcium-dependent calpain inside the living parasite was tested directly, confirming calcium-dependent cysteine-protease activity in intraerythrocytic trophozoites.\",\n      \"evidence\": \"live-cell fluorogenic substrate (Z-Phe-Arg-MCA) assays with E-64 and ALLN inhibition and Ca2+ modulation by calmidazolium and thapsigargin\",\n      \"pmids\": [\"25281458\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"the fluorogenic substrate is not Pcalp-specific, so activity attribution is inferential\",\n        \"the source and dynamics of the activating Ca2+ signal are not resolved\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Two studies probed pharmacological and physical context: organotelluranes were identified as inhibitors of the calcium-stimulated protease, and a candidate Hsp60 partnership was reported.\",\n      \"evidence\": \"intracellular protease inhibition assays with Ca2+-ATPase discrimination and growth assays (3D7, W2); co-immunoprecipitation, immunofluorescence co-localization, and mizoribine treatment for the Hsp60 link\",\n      \"pmids\": [\"26384965\", \"26797432\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"organotellurane targeting is inferred without direct binding to purified Pcalp\",\n        \"Hsp60 interaction rests on a single non-reciprocal Co-IP and a non-specific inhibitor\",\n        \"functional consequence of the putative Hsp60 association is undefined\"\n      ],\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"},\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"W2\"}\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the physiological substrates cleaved by Pcalp to drive the ring-to-trophozoite transition and S-phase entry, and how its nucleolar localization couples to this cell-cycle role, remain unknown.\",\n      \"evidence\": \"no timeline discovery defines an endogenous Pcalp substrate or a mechanistic link between localization and cell-cycle function\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"no validated endogenous substrate identified\",\n        \"regulation in the absence of a calpastatin homolog is unexplained\",\n        \"reconciliation of nucleolar versus cytoplasmic localization reports is unresolved\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004198\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0008234\", \"supporting_discovery_ids\": [2, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005737\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0022402\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0051301\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"Pf-Hsp60 (putative, single non-reciprocal Co-IP)\"],\n    \"other_free_text\": [\n      \"N-terminally myristoylated at Gly2 and palmitoylated at Cys3 and Cys22; palmitoylation status controls nucleolar versus nuclear localization [#0]\",\n      \"Active form is catalytic subdomain IIa functioning as a monomer with a Cys-His-Asn catalytic triad [#2]\",\n      \"Activity is calcium-dependent in live trophozoites and inhibited by E-64 and ALLN [#3]\",\n      \"Essential gene: proteolytic activity required, depletion delays ring-to-trophozoite transition and blocks S-phase entry [#1]\",\n      \"No calpastatin homolog identified in the P. falciparum genome [#7]\",\n      \"Reported inhibited by organotellurane compounds [#5 correction: #4]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1362400","name":null,"product":"calpain","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1138400","name":null,"product":"calpain, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1108900","name":null,"product":"calpain, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"Pcalp","evaluation":null}